Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 16, 2013
SALT LAKE CITY (BUSINESS WIRE - September 16, 2013) Lipocine Inc. ("Lipocine") (OTCQB⁄OTCBB:LPCN), a specialty pharmaceutical company, announced today that Morgan Brown has joined the Company as...
-
Aug 22, 2013
SALT LAKE CITY (BUSINESS WIRE - August 22, 2013) Lipocine Inc.(OTCQB⁄OTCBB:LPCN), a specialty pharmaceutical company, announced today that it has changed its trading symbol from OTCBB:MBARD to...
-
Jul 31, 2013
SALT LAKE CITY (BUSINESS WIRE - July 31, 2013) Lipocine, Inc. (OTCBB:MBARD), a specialty pharmaceutical company, announced today that it has closed its previously announced private placement with...
-
Jun 26, 2013
SALT LAKE CITY (BUSINESS WIRE - July 26, 2013) Lipocine, Inc. (OTCBB:MBARD), a specialty pharmaceutical company, announced today that it has entered into securities purchase agreements with gross...
-
May 7, 2013
Press Release: LifeSci Advisors (NEW YORK, NY--Marketwired - May 7, 2013) - LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences...
-
Apr 5, 2013
(Salt Lake City, April 5, 2013) - Lipocine Inc. (www.lipocine.com), a biopharmaceutical company focused on developing innovative oral hormone therapies for men's and women's health, today...
-
Dec 4, 2012
(Salt Lake City, December 5, 2012) - Lipocine Inc. (www.lipocine.com) announced today that the Company recently met with FDA and received guidance and go ahead for the Company's pivotal Phase III...
-
Jul 6, 2011
Salt Lake City, Utah, July 6, 2011 Lipocine announces that Dr. William Higuchi, Lipocine co-founder and Chairman of the Board, was awarded the 'Order of The Rising Sun' by the Japanese Government...
-
Jan 28, 2011
Lipocine Inc. Salt Lake City, Utah, January 28, 2011 (www.lipocine.com) announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent...
-
Nov 2, 2010
Lipocine Inc. announced today that it has been awarded four cash grants totaling approximately $978,000 under the U.S. Government’s Qualifying Therapeutic Discovery Project (“QTDP”) program....